Target intelligence / Profile preview

Sigma receptor (σR)

Target
σR
Molecular classification
Chaperone protein, Receptor, Endoplasmic reticulum-resident protein
01

Overview

Sigma receptors are a unique class of non-opioid, non-dopaminergic intracellular proteins located primarily in the endoplasmic reticulum (ER) and its mitochondria-associated membranes (MAM). They are classified into two distinct subtypes: the Sigma-1 receptor, which functions as a molecular chaperone to ensure proper protein folding and calcium signaling, and the Sigma-2 receptor, recently identified as the transmembrane protein 197 (TMEM97), which is involved in cholesterol homeostasis and cell proliferation. These receptors play a critical role in cellular homeostasis, particularly in response to ER stress and oxidative stress, making them vital for neuronal survival and plasticity. In clinical contexts, Sigma-1 agonists are being investigated for neurodegenerative conditions like Alzheimer's and ALS due to their neuroprotective properties, while Sigma-2 ligands are primarily explored as biomarkers and therapeutic targets in oncology for their ability to modulate tumor cell viability. Their wide distribution across the central nervous system and peripheral tissues allows them to influence a variety of physiological processes, including pain perception, mood regulation, and immune response.

Other names
Sigma non-opioid intracellular receptorSigma-1 receptorSigma-2 receptorσ1Rσ2RTMEM97 (Sigma-2)
02

Mechanism of action

Sigma-1 receptors act as ligand-operated molecular chaperones that stabilize proteins at the mitochondria-associated ER membrane (MAM), regulating calcium signaling and ER stress responses. Sigma-2 receptors (TMEM97) modulate cholesterol trafficking and cell proliferation, with agonists often inducing apoptosis in tumor cells.

03

Biological functions

Protein foldingCalcium signalingLipid transportNeuroprotectionModulation of ion channelsCholesterol homeostasisCell survival signaling
04

Disease associations

Neurodegenerative diseaseCancerNeuropathic painDepressionSchizophreniaAmyotrophic lateral sclerosis (ALS)Alzheimer's disease
05

Safety considerations

Potential for off-target CNS effectsComplex polypharmacology with opioid and dopaminergic systemsPotential for drug-drug interactions due to high affinity for various psychotropic agents
06

Interacting drugs

Haloperidol

9 more in the full profile.

07

Biomarkers

[11C]SA4503 (PET tracer)[18F]SFE (PET tracer)[18F]ISO-1 (Sigma-2 PET tracer)

Beyond the preview

Go deeper on Sigma receptor (σR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sigma receptor (σR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call